LivaNova
LIVN
180 hedge funds and large institutions have $2.06B invested in LivaNova in 2020 Q3 according to their latest regulatory filings, with 25 funds opening new positions, 44 increasing their positions, 88 reducing their positions, and 28 closing their positions.
0.91% less ownership
Funds ownership: 94.92% → 94.01% (-0.91%)
2% less funds holding
Funds holding: 183 → 180 (-3)
8% less capital invested
Capital invested by funds: $2.24B → $2.06B (-$174M)
11% less first-time investments, than exits
New positions opened: 25 | Existing positions closed: 28
50% less repeat investments, than reductions
Existing positions increased: 44 | Existing positions reduced: 88
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $303K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Barrow, Hanley, Mewhinney & Strauss
Dallas,
Texas
|
+$78M |
| 2 |
Goldman Sachs
New York
|
+$64.8M |
| 3 |
MC
Maverick Capital
Dallas,
Texas
|
+$57.8M |
| 4 |
Harris Associates
Chicago,
Illinois
|
+$26.8M |
| 5 |
Diamond Hill Capital Management
Columbus,
Ohio
|
+$24.1M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
HM
HealthCor Management
New York
|
-$69.6M |
| 2 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$41.9M |
| 3 |
Franklin Resources
San Mateo,
California
|
-$40.1M |
| 4 |
Barclays
London,
United Kingdom
|
-$32.3M |
| 5 |
Marshall Wace
London,
United Kingdom
|
-$19.5M |
LIVN Hedge Fund Activity: Q3 2020 in Review
180 of the 4,956 institutional investors tracked by Wall St. Rank reported a position in LivaNova (LIVN) for Q3 2020, worth a combined $2.06B — down 7.8% from $2.24B a quarter earlier.
Sellers outnumbered buyers: 28 funds closed out of LIVN and 25 opened new positions — a net loss of 3 holders — while 88 trimmed existing stakes and 44 added.
The largest buyer was Barrow, Hanley, Mewhinney & Strauss, adding an estimated $78M. The largest seller was HealthCor Management, exiting entirely with an estimated $69.6M sold.
- 180 institutional investors held LivaNova (LIVN) as of Q3 2020, down from 183 in Q2 2020.
- Funds reported $2.06B of LivaNova stock for Q3 2020, down 7.8% quarter-over-quarter.
- 25 funds opened new LivaNova positions in Q3 2020 and 28 closed out, a net change of -3 holders.
- The largest LivaNova buyer in Q3 2020 was Barrow, Hanley, Mewhinney & Strauss, an estimated $78M added.
- The largest LivaNova seller in Q3 2020 was HealthCor Management, an estimated $69.6M sold.
Based on aggregated 13F filings for Q3 2020.